Seckinger, A., Hillengass, J., Emde, M., Beck, S., Kimmich, C., Dittrich, T., . . . Hose, D. (2018). CD38 as Immunotherapeutic Target in Light Chain Amyloidosis and Multiple Myeloma—Association With Molecular Entities, Risk, Survival, and Mechanisms of Upfront Resistance. Front Immunol.
Styl cytowania ChicagoSeckinger, Anja, et al. "CD38 As Immunotherapeutic Target in Light Chain Amyloidosis and Multiple Myeloma—Association With Molecular Entities, Risk, Survival, and Mechanisms of Upfront Resistance." Front Immunol 2018.
Styl cytowania MLASeckinger, Anja, et al. "CD38 As Immunotherapeutic Target in Light Chain Amyloidosis and Multiple Myeloma—Association With Molecular Entities, Risk, Survival, and Mechanisms of Upfront Resistance." Front Immunol 2018.